vimarsana.com

Latest Breaking News On - Institutional trading of roivant sciences - Page 1 : vimarsana.com

Roivant Sciences Ltd (NASDAQ:ROIV) Receives Consensus Rating of Moderate Buy from Brokerages

Shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) have been given an average rating of “Moderate Buy” by the ten research firms that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. […]

HC Wainwright Reaffirms Buy Rating for Roivant Sciences (NASDAQ:ROIV)

Roivant Sciences (NASDAQ:ROIV – Get Free Report)‘s stock had its “buy” rating reiterated by equities researchers at HC Wainwright in a report issued on Monday, Benzinga reports. They presently have a $18.00 target price on the stock. HC Wainwright’s price target indicates a potential upside of 64.53% from the company’s previous close. Other research analysts […]

HC Wainwright Boosts Roivant Sciences (NASDAQ:ROIV) Price Target to $18 00

Roivant Sciences (NASDAQ:ROIV – Free Report) had its price target upped by HC Wainwright from $17.00 to $18.00 in a research note released on Wednesday morning, Benzinga reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Roivant Sciences’ Q1 2025 earnings at ($0.25) EPS, Q2 2025 earnings […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.